• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板纤维蛋白与三氧化矿物凝聚体作为恒牙牙根发育不全时活髓切断术药物的比较评价:一项随机对照试验

Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial.

作者信息

Keswani Deepa, Pandey Ramesh K, Ansari Afroz, Gupta Shalini

机构信息

Department of Pedodontics and Preventive Dentistry, King George's Medical University, Lucknow, India.

Department of Pedodontics and Preventive Dentistry, King George's Medical University, Lucknow, India.

出版信息

J Endod. 2014 May;40(5):599-605. doi: 10.1016/j.joen.2014.01.009. Epub 2014 Mar 6.

DOI:10.1016/j.joen.2014.01.009
PMID:24767550
Abstract

INTRODUCTION

The purpose of this study was to evaluate and compare, clinically and radiographically, the effects of platelet-rich fibrin (PRF) and mineral trioxide aggregate (MTA) as pulpotomy agents in permanent teeth with incomplete root development.

METHODS

A total number of 70 children requiring pulpotomy in 70 permanent molars with incomplete root development were screened. Sixty-two patients met the inclusion criteria and were enrolled in the study. The patients were randomly allocated equally in 2 treatment groups. MTA pulpotomy was performed in group A (the control group), and PRF pulpotomy was performed in group B (the experimental group). The treated teeth were restored with amalgam followed by stainless steel crowns. Clinical and radiographic evaluations were performed after 6, 12, and 24 months. Thus, the data obtained were blindly analyzed using the chi-square test.

RESULTS

There was no significant difference between the 2 groups in terms of clinical and radiologic success. Radiographically, all available cases (53 teeth) showed evidence of root growth and canal narrowing. Complete apical closure was observed in 88.8% in the PRF group (experimental group) and 80.07% of roots in the MTA group (control group), respectively, at 24 months.

CONCLUSIONS

PRF could be used as a suitable biological and economic alternative to MTA in pulpotomy procedures of permanent teeth with incomplete root development.

摘要

引言

本研究旨在从临床和影像学方面评估和比较富血小板纤维蛋白(PRF)和三氧化矿物凝聚体(MTA)作为恒牙牙根发育不全时牙髓切断术药物的效果。

方法

筛选出70颗恒牙牙根发育不全需要进行牙髓切断术的儿童。62名患者符合纳入标准并被纳入研究。患者被随机平均分为2个治疗组。A组(对照组)进行MTA牙髓切断术,B组(试验组)进行PRF牙髓切断术。治疗后的牙齿用汞合金修复,然后戴上不锈钢冠。在6个月、12个月和24个月后进行临床和影像学评估。因此,使用卡方检验对获得的数据进行盲法分析。

结果

两组在临床和影像学成功率方面没有显著差异。影像学上,所有可用病例(53颗牙齿)均显示出牙根生长和根管变窄的迹象。在24个月时,PRF组(试验组)88.8%的牙根和MTA组(对照组)80.07%的牙根观察到根尖完全闭合。

结论

在恒牙牙根发育不全的牙髓切断术过程中,PRF可作为MTA合适的生物和经济替代品。

相似文献

1
Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial.富血小板纤维蛋白与三氧化矿物凝聚体作为恒牙牙根发育不全时活髓切断术药物的比较评价:一项随机对照试验
J Endod. 2014 May;40(5):599-605. doi: 10.1016/j.joen.2014.01.009. Epub 2014 Mar 6.
2
Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.用富钙混合水泥或三氧化物聚合体对暴露龋的未成熟恒磨牙行活髓切断术:一项随机临床试验。
Int J Paediatr Dent. 2013 Jan;23(1):56-63. doi: 10.1111/j.1365-263X.2012.01224.x. Epub 2012 Feb 6.
3
Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis).矿物三氧化物凝聚体与氢氧化钙作为年轻恒牙活髓切断术药物(根尖诱导成形术)的比较。
Pediatr Dent. 2006 Sep-Oct;28(5):399-404.
4
Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.富血小板纤维蛋白与三氧化矿物凝聚体作为乳磨牙牙髓切断术药物的临床与影像学比较
J Indian Soc Pedod Prev Dent. 2017 Oct-Dec;35(4):367-373. doi: 10.4103/JISPPD.JISPPD_178_17.
5
Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.乳牙活髓切断术中使用矿物三氧化物凝聚体和甲醛甲酚作为牙髓药物的比较。
Br Dent J. 2008 Jun 14;204(11):E20. doi: 10.1038/sj.bdj.2008.319. Epub 2008 Apr 18.
6
Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.乳牙活髓切断术中三氧化矿物凝聚体与甲醛甲酚的比较:初步报告
Pediatr Dent. 2001 Jan-Feb;23(1):15-8.
7
A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.三氧化矿物凝聚体用于龋源性露髓恒牙部分活髓切断术的前瞻性临床研究。
J Endod. 2006 Aug;32(8):731-5. doi: 10.1016/j.joen.2005.12.008. Epub 2006 Jun 23.
8
MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.在牙科公共卫生环境中,MTA活髓切断术作为儿童恒牙根管治疗的替代方法。
J Dent. 2014 Nov;42(11):1390-5. doi: 10.1016/j.jdent.2014.06.007. Epub 2014 Jun 26.
9
Second-generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report.第二代血小板浓缩物(PRF)作为牙髓炎恒磨牙牙髓切断术的药物:病例报告。
Int Endod J. 2012 Jan;45(1):105-12. doi: 10.1111/j.1365-2591.2011.01973.x. Epub 2011 Nov 14.
10
Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.用MTA和波特兰水泥对人类乳磨牙进行牙髓切断术:一项随机对照试验。
Br Dent J. 2009 Aug 8;207(3):E5; discussion 128-9. doi: 10.1038/sj.bdj.2009.665. Epub 2009 Jul 24.

引用本文的文献

1
Survival of direct resin composites versus stainless-steel crowns as coronal restorations following pulpotomy in young permanent first molars: a retrospective cohort study using propensity score-matched analysis.年轻恒牙第一磨牙活髓切断术后直接树脂复合材料与不锈钢冠作为冠修复体的存留情况:一项使用倾向评分匹配分析的回顾性队列研究
Eur Arch Paediatr Dent. 2025 Jun 25. doi: 10.1007/s40368-025-01074-x.
2
Tomographic evaluation of apexogenesis with human treated dentin matrix in young permanent molars: a split-mouth randomized controlled clinical trial.用人处理过的牙本质基质对年轻恒牙进行根尖诱导成形术的断层扫描评估:一项双盲随机对照临床试验。
BMC Oral Health. 2025 May 7;25(1):692. doi: 10.1186/s12903-025-05997-1.
3
Clinical and radiographic assessment of mineral trioxide aggregate with platelet rich fibrin as pulp capping biomaterials: a 12-month randomized trial.
以富血小板纤维蛋白作为盖髓生物材料的三氧化矿物凝聚体的临床和影像学评估:一项为期12个月的随机试验
Sci Rep. 2025 Apr 15;15(1):12874. doi: 10.1038/s41598-025-96056-w.
4
Overall success rate of permanent teeth pulpotomy using ProRoot MTA: A systematic review and meta-analysis of randomized clinical trials.使用ProRoot MTA进行恒牙牙髓切断术的总体成功率:一项随机临床试验的系统评价和荟萃分析。
PLoS One. 2025 Apr 10;20(4):e0320838. doi: 10.1371/journal.pone.0320838. eCollection 2025.
5
Management strategies for pulpitis in vital permanent teeth in children and adolescents: a systematic review and meta-analysis of randomized clinical trials.儿童和青少年恒牙牙髓病的管理策略:随机临床试验的系统评价和荟萃分析
Eur Arch Paediatr Dent. 2025 Mar 21. doi: 10.1007/s40368-025-01021-w.
6
Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Human Amniotic Membrane Pulpotomy in Primary Molars: A Randomized Clinical Trial.乳牙中三氧化矿物凝聚体与人类羊膜牙髓切断术的临床及影像学评估:一项随机临床试验
Int J Clin Pediatr Dent. 2024 Jun;17(6):641-646. doi: 10.5005/jp-journals-10005-2857.
7
Efficacy of pulpotomy for permanent teeth with carious pulp exposure: A systematic review and meta-analysis of randomized controlled trials.活髓切断术治疗露髓的恒牙的疗效:一项随机对照试验的系统评价和荟萃分析。
PLoS One. 2024 Jul 5;19(7):e0305218. doi: 10.1371/journal.pone.0305218. eCollection 2024.
8
Role of Platelet Concentrates in Dental-Pulp Regeneration: A Systematic Review of Randomized Clinical Trials.血小板浓缩物在牙髓再生中的作用:随机临床试验的系统评价
J Dent (Shiraz). 2024 Jun 1;25(2):97-107. doi: 10.30476/dentjods.2023.96000.1912. eCollection 2024 Jun.
9
Outcome assessment methods of bioactive and biodegradable materials as pulpotomy agents in primary and permanent teeth: a scoping review.生物活性和可生物降解材料作为乳牙和恒牙盖髓剂的疗效评估方法:范围综述。
BMC Oral Health. 2024 Apr 27;24(1):496. doi: 10.1186/s12903-024-04221-w.
10
Comparative efficacy of materials used in patients undergoing pulpotomy or direct pulp capping in carious teeth: A systematic review and meta-analysis.在龋齿患者行活髓切断术或直接盖髓术中应用不同材料的疗效比较:系统评价和荟萃分析。
Clin Exp Dent Res. 2023 Dec;9(6):1129-1148. doi: 10.1002/cre2.767. Epub 2023 Sep 14.